Proactive Investors - Run By Investors For Investors

US$1mln grant is 'testament to the great science' ongoing at Redx, CSO says

Richard Armer, chief scientific officer at drug discovery company Redx (LON:REDX), talks to Proactive Investors about the US$1mln grant the company received to accelerate the development of new antibiotics that combat drug resistant Gram-negative bacteria.

"It's a testament to the great science that has been ongoing at Redx," he says.

Meet Sayona Mining Ltd, Lithium Power International Ltd, Elementos, Tyranna Resources and Bryah Resources at our event, Sydney, 26 July 2017. Register here »
View full REDX profile View Profile

Redx Pharma Plc Timeline

CN Research
April 06 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use